Endothelial Dysfunction Clinical Trial
Official title:
Endothelial Dysfunction As A Predictor Of Perioperative Outcome In Major Thoracic Surgery - An Observational Study
The goal of this clinical research study is to learn whether the inability of certain blood vessel cells (endothelial cells) to function properly may help researchers to predict who is at risk for complications after surgery and whether this dysfunction contributes to complications after surgery. This study will use a blood test to quantify the number of cells that are destined to become endothelial cells.
A small group of patients (about 12 out of every 100) are at risk of developing
complications, for example lung infection, after their surgery. Researchers do not always
know which patient is at risk or the reason why some patients develop these complications.
Your participation in this study may help researchers to understand who is at risk and also
the mechanism of some of the complications.
The inner layer of cells of blood vessels are called endothelial cells. This layer of cells
plays a vital role in the normal function of blood vessels, including blood clotting and
inflammation. Certain conditions, such as aging, smoking, high cholesterol, and some
chemotherapies cause these cells to not function properly. Researchers can test whether these
cells function properly by doing two simple tests - one is a blood test and the other uses
ultrasound and temperature probes on the finger to look at the ability of arm blood vessels
to dilate (expand).
The way your cells function will be tested within a month before your scheduled chemotherapy
/ radiation (if applicable), and again within a month before your major chest surgery. This
will be done on those patients with surgery planned or scheduled.
About 2 tablespoons of blood will be drawn to measure the number of circulating blood cells
that become endothelial cells.
During your scheduled surgery, the researcher will also collect just over a teaspoon of blood
at the beginning of the surgery for an additional endothelial risk assessment and a small
sample of lung tissue, if available. Tissue removed during long surgery is usually thrown
away if it is not needed for diagnosis and or treatment purposes. The lung tissue sample
collected for this research study will only be taken from lung tissue that is to be
discarded. The lung tissue will be used to determine the amount of a naturally occurring
substance thought to play a role in recruiting blood cells to repair injured lung tissue.
Blood samples (about 2 tablespoons) will also be collected after exercise, during your
surgery, 24 hours after your surgery, and at 5 days after surgery or the time you discharge
from the hospital (which ever is shorter). These blood samples will also be collected at your
routinely schedule post operative clinic visits at 1 month, 6 months, and 1 year after
surgery. The samples will be used to determine the amount of endothelial cells in the blood
stream.
For healthy volunteers, blood samples (about 2 tablespoons) will be collected at baseline
(prior to exercising), 15-30 minutes past peak exercise, 3 hours past peak exercise and at 24
hours past past peak exercise.
Data will be collected on you for 30 days after your surgery, and during the 1 year
follow-up. These data will then be matched with the amount of cell function as measured
before surgery to see if these tests may be used to help predict which patients are at
increased risk for complications. No other measurements will be done and this study will not
change your surgical procedure or lengthen your hospital stay.
This is an investigational study. About 90 patients will take part in this study. All will be
enrolled at The University of Texas (UT) MD Anderson Cancer Center (MDACC).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT04156711 -
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
|
N/A | |
Recruiting |
NCT06133634 -
Fisetin to Improve Vascular Function in Older Adults
|
Phase 1/Phase 2 | |
Completed |
NCT05872139 -
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
|
N/A | |
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02334839 -
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction
|
N/A | |
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Completed |
NCT01691404 -
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Terminated |
NCT01412216 -
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
|
Phase 2 | |
Completed |
NCT01319344 -
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
|
Phase 3 | |
Completed |
NCT00848302 -
Endothelial Function in Human Arteries
|
Early Phase 1 | |
Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT00990730 -
Atherosclerosis in Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00532844 -
A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
|
Phase 2 | |
Completed |
NCT00376246 -
Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects
|
Phase 4 | |
Completed |
NCT00775099 -
Combustion Derived Air Pollution and Vascular Function
|
N/A |